Optimal tolerability and high efficacy of a modified schedule of lapatinib–capecitabine in advanced breast cancer patients

by Gamucci, T., Moscetti, L., Mentuccia, L., Pizzuti, L., Mauri, M., Zampa, G., Pavese, I., Sperduti, I., Vaccaro, A., Vici, P.
Published 2013

Recurrence risk in small, node-negative, early breast cancer: a multicenter retrospective analysis

by Gamucci, T., Vaccaro, A., Ciancola, F., Pizzuti, L., Sperduti, I., Moscetti, L., Longo, F., Fabbri, M. A., Giampaolo, M. A., Mentuccia, L., Di Lauro, L., Vici, P.
Published 2013

Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies

by Vici, P, Pizzuti, L, Mariani, L, Zampa, G, Santini, D, Di Lauro, L, Gamucci, T, Natoli, C, Marchetti, P, Barba, M, Maugeri-Saccà, M, Sergi, D, Tomao, F, Vizza, E, Di Filippo, S, Paolini, F, Curzio, G, Corrado, G, Michelotti, A, Sanguineti, G, Giordano, A, De Maria, R, Venuti, A
Published 2016